Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT₁ Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice

• Kazi Rafiq ,

  * E-mail: krafiq73@yahoo.com

  Affiliation Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan

  ⨯
• Shamshad J. Sherajee,

  Affiliation Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan

  ⨯
• Hirofumi Hitomi,

  Affiliation Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan

  ⨯
• Daisuke Nakano,

  Affiliation Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan

  ⨯
• Hiroyuki Kobori,

  Affiliation Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan

  ⨯
• Koji Ohmori,

  Affiliation Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan

  ⨯
• Hirohito Mori,

  Affiliation Gastroenterology, Faculty of Medicine, Kagawa University, Kagawa, Japan

  ⨯
• Hideki Kobara,

  Affiliation Gastroenterology, Faculty of Medicine, Kagawa University, Kagawa, Japan

  ⨯
• Tsutomu Masaki,

  Affiliation Gastroenterology, Faculty of Medicine, Kagawa University, Kagawa, Japan

  ⨯
• Masakazu Kohno,

  Affiliation Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan

  ⨯
• Akira Nishiyama

  Affiliation Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan

  ⨯